Dipti M. Karamchandani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dipti M. Karamchandani has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Hwajeong Lee
Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, USA
5 shared publications - Raul S. Gonzalez
Department of Pathology and Laboratory Medicine Emory University Hospital Atlanta GA USA
4 shared publications - Runjan Chetty
Department of Histopathology, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
4 shared publications - Brian Cox
Pacific Rim Pathology San Diego California USA
3 shared publications Christina A. Arnold
Department of Pathology, University of Colorado, Aurora, CO, 80045, USA
3 shared publicationsMaria Westerhoff
From the Department of Pathology, University of Michigan, Ann Arbor (Westerhoff)
3 shared publications
Latest Publications
- 21 October 2026
- Published by Wiley in Histopathology
Grading colorectal adenocarcinoma: interobserver agreement between American Joint Committee on Cancer and World Health Organization criteria and revisiting diagnostic challenges
Aim: The current American Joint Committee on Cancer (AJCC8) manual grades colorectal adenocarcinoma (CRC) based on the percentage of gland formation. The World Health Organization 5th ed (WHO5) and 6th ed (WHO6) grade based on the least differentiated component; WHO6 specifies a minimum 0.196 mm 2 area of the least‐differentiated component away from the invasive front to merit a high‐grade diagnosis. We studied the interobserver agreement and challenges among pathologists when grading CRC using the above grading systems. Methods and results: Five gastrointestinal pathologists reviewed 100 scanned CRC slides and graded each slide per the provided criteria in (a) WHO5, (b) WHO6, (c) AJCC8 and (d) their clinical practice. A post‐survey questionnaire was also provided. The Fleiss multirater kappa among the five reviewers was similar using WHO6 (0.730, P < 0.001) and two‐tiered (low vs. high) AJCC8 (0.731, P < 0.001) and was higher than WHO5 (0.655, P < 0.001) grading criteria; the agreement was substantial for all 3 grading systems. Significantly more tumours were called high‐grade when using WHO6 (average: 34.4 cases) and WHO5 (average: 33.6 cases) as compared to AJCC8 (average: 11.8 cases) grading criteria ( P < 0.01). All reviewers were unanimous in handling certain scenarios (e.g. discounting invasive front tumour buds with WHO grading), but were discordant on certain scenarios (e.g. assessment of stroma‐rich areas). Conclusions: While inter‐observer agreement improved with WHO6 versus WHO5, the persistent upgrading of tumours using the WHO scheme may affect treatment algorithms. Synchronization of grading criteria with validation in prospective studies with clinical outcomes is crucial.
- 21 October 2026
- Published by Wiley in Histopathology
Grading colorectal adenocarcinoma: interobserver agreement between American Joint Committee on Cancer and World Health Organization criteria and revisiting diagnostic challenges
Aim: The current American Joint Committee on Cancer (AJCC8) manual grades colorectal adenocarcinoma (CRC) based on the percentage of gland formation. The World Health Organization 5th ed (WHO5) and 6th ed (WHO6) grade based on the least differentiated component; WHO6 specifies a minimum 0.196 mm 2 area of the least‐differentiated component away from the invasive front to merit a high‐grade diagnosis. We studied the interobserver agreement and challenges among pathologists when grading CRC using the above grading systems. Methods and results: Five gastrointestinal pathologists reviewed 100 scanned CRC slides and graded each slide per the provided criteria in (a) WHO5, (b) WHO6, (c) AJCC8 and (d) their clinical practice. A post‐survey questionnaire was also provided. The Fleiss multirater kappa among the five reviewers was similar using WHO6 (0.730, P < 0.001) and two‐tiered (low vs. high) AJCC8 (0.731, P < 0.001) and was higher than WHO5 (0.655, P < 0.001) grading criteria; the agreement was substantial for all 3 grading systems. Significantly more tumours were called high‐grade when using WHO6 (average: 34.4 cases) and WHO5 (average: 33.6 cases) as compared to AJCC8 (average: 11.8 cases) grading criteria ( P < 0.01). All reviewers were unanimous in handling certain scenarios (e.g. discounting invasive front tumour buds with WHO grading), but were discordant on certain scenarios (e.g. assessment of stroma‐rich areas). Conclusions: While inter‐observer agreement improved with WHO6 versus WHO5, the persistent upgrading of tumours using the WHO scheme may affect treatment algorithms. Synchronization of grading criteria with validation in prospective studies with clinical outcomes is crucial.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Clinicopathologic Characteristics of Rare Appendiceal Collision Tumors: A Multi-Center Case Series and Literature Review
Appendiceal tumors are uncommon, and their coexistence as collision tumors is exceedingly rare, with fewer than 20 cases reported to date. The objective is to report a multi-center case series and literature review of appendiceal collision tumors, providing a comprehensive summary of clinicopathological features and outcomes. Electronic records from four tertiary centers (2016–2024) were searched. Cases with appendiceal collision tumors composed of a neuroendocrine tumor (NET) and a second component of low- or high-grade appendiceal mucinous neoplasm (LAMN/HAMN) or adenocarcinoma were included. Additional cases with the same diagnostic combinations were identified through a PubMed literature search since 2000. Clinical, pathologic, and survival data were collected and analyzed. Thirty-two cases were identified, including 17 multi-institutional and 16 literature-derived cases, with an estimated incidence of 0.11% among appendectomies. Most tumors consisted of localized NET and LAMN. Gastrointestinal (GI) symptoms were present in 62.5-65.6% of cases, and tumors were identified by imaging in 53.1-75.0%. Outcome tracks the higher-stage and grade component. Patients with localized tumors had excellent outcomes (2-year progression-free survival [PFS] and overall survival [OS]: 100%). In contrast, cases with metastatic LAMN/HAMN had 2-year PFS 66.7% and OS 100%, while those with metastatic adenocarcinoma had 2-year PFS 0% and OS 66.7%.This study represents the largest series and literature review of appendiceal collision tumors to date. These rare tumors most often consist of localized NET and LAMN, typically present with GI symptoms, are often detected by imaging. The prognosis is dictated by the component of higher stage and grade.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessClinicopathologic Characteristics of Rare Appendiceal Collision Tumors: A Multi-Center Case Series and Literature Review
Appendiceal tumors are uncommon, and their coexistence as collision tumors is exceedingly rare, with fewer than 20 cases reported to date. The objective is to report a multi-center case series and literature review of appendiceal collision tumors, providing a comprehensive summary of clinicopathological features and outcomes. Electronic records from four tertiary centers (2016–2024) were searched. Cases with appendiceal collision tumors composed of a neuroendocrine tumor (NET) and a second component of low- or high-grade appendiceal mucinous neoplasm (LAMN/HAMN) or adenocarcinoma were included. Additional cases with the same diagnostic combinations were identified through a PubMed literature search since 2000. Clinical, pathologic, and survival data were collected and analyzed. Thirty-two cases were identified, including 17 multi-institutional and 16 literature-derived cases, with an estimated incidence of 0.11% among appendectomies. Most tumors consisted of localized NET and LAMN. Gastrointestinal (GI) symptoms were present in 62.5-65.6% of cases, and tumors were identified by imaging in 53.1-75.0%. Outcome tracks the higher-stage and grade component. Patients with localized tumors had excellent outcomes (2-year progression-free survival [PFS] and overall survival [OS]: 100%). In contrast, cases with metastatic LAMN/HAMN had 2-year PFS 66.7% and OS 100%, while those with metastatic adenocarcinoma had 2-year PFS 0% and OS 66.7%.This study represents the largest series and literature review of appendiceal collision tumors to date. These rare tumors most often consist of localized NET and LAMN, typically present with GI symptoms, are often detected by imaging. The prognosis is dictated by the component of higher stage and grade.
- 22 January 2026
- Published by Elsevier in Human Pathology
- Vol. 171, 106054
Epstein-Barr virus associated gastric carcinoma: A clinicopathologic study with recognition of a distinctive reticular histologic pattern
- 22 January 2026
- Published by Elsevier in Human Pathology
- Vol. 171, 106054
Epstein-Barr virus associated gastric carcinoma: A clinicopathologic study with recognition of a distinctive reticular histologic pattern
- 12 August 2025
- Published by Wiley in Histopathology
- Vol. 87 (6) , 933-942
Composite gangliocytoma/neuroma and neuroendocrine tumour: a contemporary analysis of 71 cases shows risk factors for metastasis
Aims: To describe the clinicopathological features of composite gangliocytoma/neuroma and neuroendocrine tumour (CoGNET) and possible risk factors for nodal metastasis. Methods and results: We compiled a cohort of 71 cases from 19 institutions. Mean patient age was 58 years. Thirty‐eight (54%) patients were male. Most patients (65%) had symptoms, including abdominal pain (20%) and gastrointestinal bleeding (19%). Most cases (70%) were described as a subepithelial mass/nodule, and nearly half (45%) were located in the 2nd portion of the duodenum. Mean tumour size was 2.2 cm, and most (87%) were well‐circumscribed. Nearly all cases (96%) demonstrated all three histologic components, with the epithelioid component being the most predominant overall (mean 59%). All cases involved the submucosa, with 7 (10%) additionally involving the muscularis propria. Solid areas of ganglion‐like cells were identified in 16/69 (23%) cases, glandular structure formation in 15/70 (21%), lymphovascular invasion (LVI) in 6/70 (9%) cases, and perineural invasion and necrosis in one case each. Nodal metastasis was identified at diagnosis in 8 (11%) cases; increased age, increased size, LVI and muscularis propria involvement were all significantly associated with nodal disease ( P < 0.05). Follow‐up data were available for 68 patients (mean 47 months); nearly all were alive without disease, though one patient developed liver metastasis after 8 months and died of the disease after 63 months. Conclusions: This largest series of CoGNET to date demonstrates that approximately 10% of cases develop nodal metastases. Large tumour size, muscularis propria involvement, advanced patient age and LVI appear to be risk factors for nodal metastasis.
- 12 August 2025
- Published by Wiley in Histopathology
- Vol. 87 (6) , 933-942
Composite gangliocytoma/neuroma and neuroendocrine tumour: a contemporary analysis of 71 cases shows risk factors for metastasis
Aims: To describe the clinicopathological features of composite gangliocytoma/neuroma and neuroendocrine tumour (CoGNET) and possible risk factors for nodal metastasis. Methods and results: We compiled a cohort of 71 cases from 19 institutions. Mean patient age was 58 years. Thirty‐eight (54%) patients were male. Most patients (65%) had symptoms, including abdominal pain (20%) and gastrointestinal bleeding (19%). Most cases (70%) were described as a subepithelial mass/nodule, and nearly half (45%) were located in the 2nd portion of the duodenum. Mean tumour size was 2.2 cm, and most (87%) were well‐circumscribed. Nearly all cases (96%) demonstrated all three histologic components, with the epithelioid component being the most predominant overall (mean 59%). All cases involved the submucosa, with 7 (10%) additionally involving the muscularis propria. Solid areas of ganglion‐like cells were identified in 16/69 (23%) cases, glandular structure formation in 15/70 (21%), lymphovascular invasion (LVI) in 6/70 (9%) cases, and perineural invasion and necrosis in one case each. Nodal metastasis was identified at diagnosis in 8 (11%) cases; increased age, increased size, LVI and muscularis propria involvement were all significantly associated with nodal disease ( P < 0.05). Follow‐up data were available for 68 patients (mean 47 months); nearly all were alive without disease, though one patient developed liver metastasis after 8 months and died of the disease after 63 months. Conclusions: This largest series of CoGNET to date demonstrates that approximately 10% of cases develop nodal metastases. Large tumour size, muscularis propria involvement, advanced patient age and LVI appear to be risk factors for nodal metastasis.
- Open Access
- 27 April 2025
- Published by Wiley in Histopathology
- Vol. 87 (3) , 478-480
Duodenal neuroendocrine tumours masquerading as peptic duodenitis, crushed lymphoid aggregates and prominent Brunner glands: some diagnostic pitfalls
- 27 April 2025
- Published by Wiley in Histopathology
- Vol. 87 (3) , 478-480
Open AccessDuodenal neuroendocrine tumours masquerading as peptic duodenitis, crushed lymphoid aggregates and prominent Brunner glands: some diagnostic pitfalls
- 28 January 2025
- Published by Wiley in Histopathology
- Vol. 86 (7) , 1101-1111
Interobserver agreement and practice patterns for grading of colorectal carcinoma: World Health Organization (WHO) classification of tumours 5th edition versus American Joint Committee on Cancer (AJCC) 8th edition staging manual
Aims: The current American Joint Committee on Cancer (AJCC) staging manual and the College of American Pathologists (CAP) colorectal carcinoma (CRC) protocol specify use of a four‐tiered grading system (i.e. grades 1–4; well‐differentiated–undifferentiated) for CRC, based on percentage of gland formation. The World Health Organization (WHO) 5th edition grades CRC into low‐grade (well‐ and moderately differentiated) and high‐grade (poorly and undifferentiated), based on the least differentiated component. We studied interobserver agreement and practice patterns among pathologists when grading CRC by these two grading systems.Methods and results: Five gastrointestinal pathologists reviewed 100 scanned CRC slides and graded the tumour on each slide, per provided criteria in (a) WHO 5th edition book, (b) AJCC manual/CAP CRC protocol and (c) their clinical practice. A questionnaire for grading selected CRC subtypes was also provided. Statistical analysis was performed using Pearson's χ2 test and Fleiss multi‐rater kappa analyses. Overall, agreement among the five reviewers when grading via WHO and AJCC criteria for low‐grade and high‐grade CRC was moderate (κ = 0.568, P < 0.001) and good (κ = 0.611, P < 0.001), respectively. All reviewers graded significantly more tumours as high‐grade when using WHO (median = 46) versus AJCC/CAP criteria (median = 20).Conclusions: Interobserver agreement was higher using the AJCC grading criteria as a two‐tiered system. Significantly more tumours were called high‐grade using the WHO criteria. This raises concerns regarding upgrading tumours, as well as potential differences in grading tumours among pathologists worldwide, based on regional preferred grading systems. Synchronisation of these two grading systems is necessary for uniform grading of CRCs throughout institutions.
- 28 January 2025
- Published by Wiley in Histopathology
- Vol. 86 (7) , 1101-1111
Interobserver agreement and practice patterns for grading of colorectal carcinoma: World Health Organization (WHO) classification of tumours 5th edition versus American Joint Committee on Cancer (AJCC) 8th edition staging manual
Aims: The current American Joint Committee on Cancer (AJCC) staging manual and the College of American Pathologists (CAP) colorectal carcinoma (CRC) protocol specify use of a four‐tiered grading system (i.e. grades 1–4; well‐differentiated–undifferentiated) for CRC, based on percentage of gland formation. The World Health Organization (WHO) 5th edition grades CRC into low‐grade (well‐ and moderately differentiated) and high‐grade (poorly and undifferentiated), based on the least differentiated component. We studied interobserver agreement and practice patterns among pathologists when grading CRC by these two grading systems.Methods and results: Five gastrointestinal pathologists reviewed 100 scanned CRC slides and graded the tumour on each slide, per provided criteria in (a) WHO 5th edition book, (b) AJCC manual/CAP CRC protocol and (c) their clinical practice. A questionnaire for grading selected CRC subtypes was also provided. Statistical analysis was performed using Pearson's χ2 test and Fleiss multi‐rater kappa analyses. Overall, agreement among the five reviewers when grading via WHO and AJCC criteria for low‐grade and high‐grade CRC was moderate (κ = 0.568, P < 0.001) and good (κ = 0.611, P < 0.001), respectively. All reviewers graded significantly more tumours as high‐grade when using WHO (median = 46) versus AJCC/CAP criteria (median = 20).Conclusions: Interobserver agreement was higher using the AJCC grading criteria as a two‐tiered system. Significantly more tumours were called high‐grade using the WHO criteria. This raises concerns regarding upgrading tumours, as well as potential differences in grading tumours among pathologists worldwide, based on regional preferred grading systems. Synchronisation of these two grading systems is necessary for uniform grading of CRCs throughout institutions.
- 12 September 2024
- Published by Wiley in Histopathology
- Vol. 86 (2) , 285-293
Spectra of well‐differentiated neuroendocrine lesions in the extrahepatic biliary system: a case series
Aims: Neuroendocrine tumours (NETs) occurring in the extrahepatic biliary system are exceedingly rare. While NETs typically manifest as mass lesions, the occurrence of microscopic neuroendocrine cell proliferation without a distinct mass remains undocumented at this location. This study aims to characterise the clinicopathological features of a series of well‐differentiated neuroendocrine lesions involving the extrahepatic biliary tree, including mass forming NETs and microscopic non‐mass‐forming neuroendocrine cell proliferation, designated neuroendocrine cell micronests (NCMs).Methods and results: Surgical resections of NETs/NCMs involving the extrahepatic bile ducts and gallbladder were identified from electronic pathology databases among seven institutions spanning from January 2011 to September 2023. Clinical and histological findings were recorded. Ten patients (four female, six male: age range = 34–75 years) were included in the study. Histopathological examination revealed visible mass‐forming lesions in four cases (1.6–14.0 cm in size), identified in the gallbladder (n = two) or extrahepatic bile duct (n = two), all diagnosed as well‐differentiated NETs. The remaining six cases revealed incidental non‐mass‐forming NCMs in either the cystic duct (n = two), common bile duct (n = three) or gallbladder (n = one), ranging from < 0.1 to 0.4 cm; four were associated with biliary lithiasis. No evidence of metastasis or recurrence was seen in the follow‐up period (range = 0.1–11.2 years).Conclusions: This study highlights the spectrum of extrahepatic biliary well‐differentiated neuroendocrine lesions, ranging from incidental microscopic NCMs to grossly apparent mass‐forming NETs, potentially requiring different clinical management. Noteworthy is the frequent association of incidental microscopic neuroendocrine cell proliferations with biliary lithiasis, indicating a potential neuroendocrine metaplastic pathogenesis that merits further exploration.
- 12 September 2024
- Published by Wiley in Histopathology
- Vol. 86 (2) , 285-293
Spectra of well‐differentiated neuroendocrine lesions in the extrahepatic biliary system: a case series
Aims: Neuroendocrine tumours (NETs) occurring in the extrahepatic biliary system are exceedingly rare. While NETs typically manifest as mass lesions, the occurrence of microscopic neuroendocrine cell proliferation without a distinct mass remains undocumented at this location. This study aims to characterise the clinicopathological features of a series of well‐differentiated neuroendocrine lesions involving the extrahepatic biliary tree, including mass forming NETs and microscopic non‐mass‐forming neuroendocrine cell proliferation, designated neuroendocrine cell micronests (NCMs).Methods and results: Surgical resections of NETs/NCMs involving the extrahepatic bile ducts and gallbladder were identified from electronic pathology databases among seven institutions spanning from January 2011 to September 2023. Clinical and histological findings were recorded. Ten patients (four female, six male: age range = 34–75 years) were included in the study. Histopathological examination revealed visible mass‐forming lesions in four cases (1.6–14.0 cm in size), identified in the gallbladder (n = two) or extrahepatic bile duct (n = two), all diagnosed as well‐differentiated NETs. The remaining six cases revealed incidental non‐mass‐forming NCMs in either the cystic duct (n = two), common bile duct (n = three) or gallbladder (n = one), ranging from < 0.1 to 0.4 cm; four were associated with biliary lithiasis. No evidence of metastasis or recurrence was seen in the follow‐up period (range = 0.1–11.2 years).Conclusions: This study highlights the spectrum of extrahepatic biliary well‐differentiated neuroendocrine lesions, ranging from incidental microscopic NCMs to grossly apparent mass‐forming NETs, potentially requiring different clinical management. Noteworthy is the frequent association of incidental microscopic neuroendocrine cell proliferations with biliary lithiasis, indicating a potential neuroendocrine metaplastic pathogenesis that merits further exploration.
- 19 February 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 77 (3) , 169-176
Essentials of macroscopic evaluation of specimens from gastrointestinal tract
An astute macroscopic examination, coupled with correlating the gross findings with clinical indication and operative notes along with judicious, yet all pertinent sectioning for pathological examination is crucial for an accurate histopathological diagnosis, eventually leading to optimal patient care. This succinct review highlights the general concepts that lay the foundation of evaluating and grossing specimens from the luminal gastrointestinal (GI) tract. We also discuss the gross evaluation and sectioning of small therapeutic resections, along with a systematic approach and rationale when grossing and submitting histological sections from larger oncological resections from the luminal GI tract. Selected site-specific considerations, for example, grossing treated rectal and oesophageal cancers or taking sections from mucinous tumours of the appendix, among others, are also discussed.
- 19 February 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 77 (3) , 169-176
Essentials of macroscopic evaluation of specimens from gastrointestinal tract
An astute macroscopic examination, coupled with correlating the gross findings with clinical indication and operative notes along with judicious, yet all pertinent sectioning for pathological examination is crucial for an accurate histopathological diagnosis, eventually leading to optimal patient care. This succinct review highlights the general concepts that lay the foundation of evaluating and grossing specimens from the luminal gastrointestinal (GI) tract. We also discuss the gross evaluation and sectioning of small therapeutic resections, along with a systematic approach and rationale when grossing and submitting histological sections from larger oncological resections from the luminal GI tract. Selected site-specific considerations, for example, grossing treated rectal and oesophageal cancers or taking sections from mucinous tumours of the appendix, among others, are also discussed.
- 22 November 2023
- Published by BMJ in Journal of Clinical Pathology
- Vol. 77 (3) , 164-168
Macroscopic examination of pathology specimens: a critical reappraisal
Meticulous macroscopic examination of specimens and tissue sampling are crucial for accurate histopathology reporting. However, macroscopy has generally received less attention than microscopy and may be delegated to relatively inexperienced practitioners with limited guidance and supervision. This introductory paper in the minisymposium, Macroscopy Under the Microscope , focuses on issues regarding macroscopic examination and tissue sampling that have been insufficiently addressed in the published literature. It highlights the importance of specimen examination and sampling, discusses some general principles, outlines challenges and suggests potential solutions. It is critical to get macroscopy right the first time as it may not be possible to rectify errors even with expert histological assessment or to retrospectively collect missing data after the specimen retention period. Dissectors must, therefore, receive adequate guidance and supervision until they are proficient in macroscopic specimen examination. We emphasise the importance of the clinical context, optimal specimen fixation, succinct and clinically relevant macroscopic descriptions, macrophotography and judicious tissue sampling. We note that current recommendations based on the number of blocks to be submitted per maximum tumour dimension are ambiguous as the amount of tissue submitted in a cassette is not standardised and it is unclear whether ‘block’ refers to a tissue block or a paraffin block. Concerns around potential oversampling of ‘therapeutic’ specimens that could result in overdiagnosis due to detection of incidentalomas are also discussed. We hope that the issues discussed in this paper will engender debate on this clinically critical aspect of pathology practice.
- 22 November 2023
- Published by BMJ in Journal of Clinical Pathology
- Vol. 77 (3) , 164-168
Macroscopic examination of pathology specimens: a critical reappraisal
Meticulous macroscopic examination of specimens and tissue sampling are crucial for accurate histopathology reporting. However, macroscopy has generally received less attention than microscopy and may be delegated to relatively inexperienced practitioners with limited guidance and supervision. This introductory paper in the minisymposium, Macroscopy Under the Microscope , focuses on issues regarding macroscopic examination and tissue sampling that have been insufficiently addressed in the published literature. It highlights the importance of specimen examination and sampling, discusses some general principles, outlines challenges and suggests potential solutions. It is critical to get macroscopy right the first time as it may not be possible to rectify errors even with expert histological assessment or to retrospectively collect missing data after the specimen retention period. Dissectors must, therefore, receive adequate guidance and supervision until they are proficient in macroscopic specimen examination. We emphasise the importance of the clinical context, optimal specimen fixation, succinct and clinically relevant macroscopic descriptions, macrophotography and judicious tissue sampling. We note that current recommendations based on the number of blocks to be submitted per maximum tumour dimension are ambiguous as the amount of tissue submitted in a cassette is not standardised and it is unclear whether ‘block’ refers to a tissue block or a paraffin block. Concerns around potential oversampling of ‘therapeutic’ specimens that could result in overdiagnosis due to detection of incidentalomas are also discussed. We hope that the issues discussed in this paper will engender debate on this clinically critical aspect of pathology practice.
- 22 September 2023
- Published by BMJ in Journal of Clinical Pathology
- Vol. 77 (12) , 842-847
Unravelling interobserver variability in gastrointestinal glandular neoplasia: a contemporary study of US and Korean pathologists
Aims Interobserver variability in the assessment of gastric neoplasia biopsies between most Western and Eastern (predominantly represented by Japanese in the literature) pathologists has been documented. It is unknown if such variability exists between the US and Korean pathologists in the current era. Methods Ten gastrointestinal (GI) pathologists from the USA (n=5) and South Korea (n=5) evaluated 100 scanned images of gastric (n=50) and colorectal (n=50) neoplasia biopsies and answered multiple questionnaires. Consensus was defined as the answer chosen by the majority. Cohen’s (κc) and Fleiss’ kappa (κf) values were calculated between the consensus of the two groups and among the raters, respectively. Results Both groups reached a consensus in the majority of cases (74%–100%) with slight to perfect intergroup (κc=0.049–1.000) and no to substantial intragroup (κf=−0.083 to 0.660) agreements. For gastric neoplasia, Korean pathologists relied heavily on cytoarchitectural atypia, whereas the US pathologists focused on stromal invasion when diagnosing adenocarcinoma. For colorectal neoplasia, the Korean pathologists identified concurrent intramucosal carcinoma when diagnosing invasive adenocarcinoma, while the presence of desmoplasia was a prerequisite for the diagnosis of invasive adenocarcinoma for the US pathologists. Conclusions For GI neoplasia biopsy interpretation, the diagnostic approach of Korean pathologists is similar to that of Eastern/Japanese pathologists. Consensus outperformed kappa statistics in capturing the magnitude of inter-rater and intergroup reliability, highlighting the potential benefit of consensus meetings to decrease the gap between Western and Eastern diagnostic approaches.
- 22 September 2023
- Published by BMJ in Journal of Clinical Pathology
- Vol. 77 (12) , 842-847
Unravelling interobserver variability in gastrointestinal glandular neoplasia: a contemporary study of US and Korean pathologists
Aims Interobserver variability in the assessment of gastric neoplasia biopsies between most Western and Eastern (predominantly represented by Japanese in the literature) pathologists has been documented. It is unknown if such variability exists between the US and Korean pathologists in the current era. Methods Ten gastrointestinal (GI) pathologists from the USA (n=5) and South Korea (n=5) evaluated 100 scanned images of gastric (n=50) and colorectal (n=50) neoplasia biopsies and answered multiple questionnaires. Consensus was defined as the answer chosen by the majority. Cohen’s (κc) and Fleiss’ kappa (κf) values were calculated between the consensus of the two groups and among the raters, respectively. Results Both groups reached a consensus in the majority of cases (74%–100%) with slight to perfect intergroup (κc=0.049–1.000) and no to substantial intragroup (κf=−0.083 to 0.660) agreements. For gastric neoplasia, Korean pathologists relied heavily on cytoarchitectural atypia, whereas the US pathologists focused on stromal invasion when diagnosing adenocarcinoma. For colorectal neoplasia, the Korean pathologists identified concurrent intramucosal carcinoma when diagnosing invasive adenocarcinoma, while the presence of desmoplasia was a prerequisite for the diagnosis of invasive adenocarcinoma for the US pathologists. Conclusions For GI neoplasia biopsy interpretation, the diagnostic approach of Korean pathologists is similar to that of Eastern/Japanese pathologists. Consensus outperformed kappa statistics in capturing the magnitude of inter-rater and intergroup reliability, highlighting the potential benefit of consensus meetings to decrease the gap between Western and Eastern diagnostic approaches.